Back to Search Start Over

Data presented on antitumor effects of immunomodulatory oligonucleotides

Source :
Drug Week. March 28, 2003, 29
Publication Year :
2003

Abstract

2003 MAR 28 - (NewsRx.com & NewsRx.net) -- Hybridon, Inc., (HYBN.OB) announced the presentation of preclinical studies of its immunomodulatory oligonucleotides (IMO) at the American Association for Cancer Research (AACR) [...]

Details

Language :
English
ISSN :
15316440
Database :
Gale General OneFile
Journal :
Drug Week
Publication Type :
News
Accession number :
edsgcl.99045809